City of Plano Defective Breast Mesh & Breast Implant Injury Attorneys: Attorney911 (The Manginello Law Firm, PLLC) Pairs Ralph Manginello’s 27+ Years of Federal Trial Experience with Lupe Peña’s Former Insurance Defense Background and Fluent Spanish Support — We Pursue Allergan BIOCELL Textured Implants (Recalled July 2019, MDL 2921 Before Judge Brian R. Martinotti, Bellwether October 19, 2026), AlloDerm, Strattice ADM, Mentor MemoryGel and GalaFLEX P4HB Bioabsorbable Scaffolds — Command of BIA-ALCL (CD30+/ALK-) and BIA-SCC Pathology Under 21 CFR Parts 803, 807 and 814 with Riegel Parallel-Claim Survivability — Litigating the Texas 2-Year Statute of Limitations and Discovery Rule Framework for City of Plano Clients — $50M+ Total Recovered and Lead Counsel in Active $10M Bermudez v. Pi Kappa Phi Institutional-Liability Case — No Fee Unless We Recover Compensation for You — Free 24/7 Consultation, 1-888-ATTY-911, Hablamos Español
Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in City of Plano: The Definitive Guide for Patients and Families The journey through breast reconstruction, whether following a mastectomy at a major center in City of Plano or an aesthetic revision in one of North Texas’s specialized surgical suites, is one built on the promise of restoration and healing. For many women in City of Plano, that promise was anchored by the use of internal support materials—acellular dermal matrix (ADM), bioabsorbable scaffolds like GalaFLEX, or synthetic surgical meshes. When these devices fail, the emotional and physical toll is catastrophic. We understand that behind every medical file is a woman in City of Plano fighting for her health, her identity, and her future. At Attorney911 (The Manginello Law Firm, PLLC), we recognize the specific crisis you are facing. Whether you were treated at a high-volume facility near the Medical City Plano corridor or a private surgical center in the Legacy West area, the reality remains: many of these devices were cleared by the FDA through a regulatory shortcut known as the 510(k) pathway, rather than a rigorous pre-market approval process. Our Managing Partner, Ralph Manginello, has spent twenty-seven…